jc
jc

News Center

Check category
/
/
/
Media Focus: Patients with valvular heart disease - just 7 minutes! Let you and your family regain health!

Media Focus: Patients with valvular heart disease - just 7 minutes! Let you and your family regain health!

  • Categories:News Channel
  • Author:
  • Origin:
  • Time of issue:2017-12-08 11:45
  • Views:

(Summary description)

Media Focus: Patients with valvular heart disease - just 7 minutes! Let you and your family regain health!

(Summary description)

  • Categories:News Channel
  • Author:
  • Origin:
  • Time of issue:2017-12-08 11:45
  • Views:
Information

  Heart valve is the heart of the blood circulation of the "door", and only this door smoothly open and close, smooth, healthy and effective blood supply to the heart, once the valve stenosis or can not close, the heart will appear lack of power or failure. It is understood that the world's existing 12 million heart valve patients each year nearly 100 million people died. China is a country with a high incidence of heart valve diseases and has more than 2 million patients, requiring more than 200,000 surgical patients annually. However, fewer than one-third of patients actually receive surgery. In China, about 150,000 patients lose their chances of surgery each year.
  Valvular disease patients how to do?
  Currently the world's most common and traditional valve treatment is through the traditional replacement of heart valve surgery, namely: thoracotomy, incision of the heart, cardiopulmonary bypass, cardiac arrest, sewn into the valve. A 30 cm incision needs to be made under the neck and manually replaced by a doctor's technique, which can take up to 3-4 hours and the patient needs to endure tremendous pain and blood loss.

 

  This is not just a question of money, but the situation in all countries of the world is the same. Limited medical conditions and patient tolerance to surgery led to about 2/3 of patients not receiving traditional surgery.
  Heart valve replacement TAVI completed in 7 minutes
  Become a valvular patient gospel
  On November 17, 2017, good news came from the Second China Western Valve Forum. As the first heart team to have completed 100 surgical TAVI surgeries in China, Huaxi Hospital of Sichuan University became the national TAVI Teaching and training base. The establishment of this base marks the transformation of TAVI technology from nationwide top-level cardiology hospitals involved in clinical research into large-scale national clinical applications.
  What is TAVI?
  TAVI is a transcatheter aortic valve placement, a leading international minimally invasive aortic valve disease treatment, TAVI surgery since 2002, the French doctors completed the first set to become a high surgical risk or not Surgical surgical treatment of aortic valve disease. With the gradual improvement of products, technology innovation, based on new technologies, the newly designed TAVI surgery, has been used for the treatment of a wide range of aortic valve disease.

 

  At present, the technology has initially formed a new treatment standard in the field of valvular surgery in our country. It takes only 7 to 10 minutes to perform aortic valve replacement using the technology of "J-Valve? Interventional Artificial Biological Valve", and the fastest can reach 2 Minutes, while the clinical patients are high-risk elderly patients, the average age of 74 years of age or older, the highest age of 87 years of age.

 

  In the future, systematic training and clinical teaching will be obtained from West China Hospital of Sichuan University before clinical application of TAVI surgically by clinical departments. Cardiac team coaches will teach them to complete TAVI operations independently. This also plays a key role in promoting the use of this technology throughout the country.
  West China team to become the first branch
  Complete the heart team of 100 TAVI operations
  On March 26, 2014, Huaxi Hospital's heart team completed the first clinical implantation of J-Valve? and the operation was successful. Then, the second and third cases ... until the fiftieth ... the sixty ... success , In the continuation of zero mortality, will keep the legend until the end of clinical studies. As a treatment for high-risk diseases, zero mortality sounds like a myth, but Huaxi team did it! In time and again to experience the complex situation and the successful completion of surgery to save the patient's illness, Huaxi's heart team deserved to stand on top of the world. They told the academy digitally that the result of zero mortality stems from the team's orderly fit, the rigorous management of surgical procedures and the demanding quality control.

 

  In October this year, Huaxi team of Sichuan University completed their 100th TAVI implantation and became the first team to complete 100 TAVI operations in China. They use the tough quality, professional technology for the clinical use of high-tech medical fields in China, continued to write the myth belongs to them.

 

Contact us

这是描述信息

+86-512-63179788(WJ) | +86-512-63036288(SZ)

这是描述信息

Building4-1,Hi-Tech Park, Wujiang, Jiangsu Province, China

C21 Building, 218 Xinghu Street, Suzhou Industrial Park, China

这是描述信息

215200

FOLLOW US

这是描述信息

Mobile Website

这是描述信息

WeChat

Copyright ©  Suzhou Jiecheng Medical Technology Co., Ltd. 

这是描述信息